ATE402412T1 - Identifikation von verbindungen zur behandlung von nachstar - Google Patents
Identifikation von verbindungen zur behandlung von nachstarInfo
- Publication number
- ATE402412T1 ATE402412T1 AT05776264T AT05776264T ATE402412T1 AT E402412 T1 ATE402412 T1 AT E402412T1 AT 05776264 T AT05776264 T AT 05776264T AT 05776264 T AT05776264 T AT 05776264T AT E402412 T1 ATE402412 T1 AT E402412T1
- Authority
- AT
- Austria
- Prior art keywords
- postcatar
- identification
- compounds
- treatment
- pco
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title 1
- 206010036346 Posterior capsule opacification Diseases 0.000 abstract 5
- 239000003446 ligand Substances 0.000 abstract 3
- 239000005557 antagonist Substances 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 238000010998 test method Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5082—Supracellular entities, e.g. tissue, organisms
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Pathology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biotechnology (AREA)
- General Physics & Mathematics (AREA)
- Microbiology (AREA)
- Toxicology (AREA)
- Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Ophthalmology & Optometry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cephalosporin Compounds (AREA)
- Pyrane Compounds (AREA)
- Medicinal Preparation (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0419145.8A GB0419145D0 (en) | 2004-08-27 | 2004-08-27 | Treatment of posterior capsule opacification |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE402412T1 true ATE402412T1 (de) | 2008-08-15 |
Family
ID=33104737
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT05776264T ATE402412T1 (de) | 2004-08-27 | 2005-08-26 | Identifikation von verbindungen zur behandlung von nachstar |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20090036464A1 (de) |
| EP (1) | EP1782065B1 (de) |
| AT (1) | ATE402412T1 (de) |
| CA (1) | CA2578117A1 (de) |
| DE (1) | DE602005008445D1 (de) |
| ES (1) | ES2310365T3 (de) |
| GB (1) | GB0419145D0 (de) |
| WO (1) | WO2006021811A2 (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0821093D0 (en) * | 2008-11-18 | 2008-12-24 | Modern Biosciences Plc | Treatment |
| GB201003124D0 (en) * | 2010-02-25 | 2010-04-14 | Univ East Anglia | Treatment of oxidative stress disorders |
| WO2011146863A1 (en) * | 2010-05-21 | 2011-11-24 | Alcon Research, Ltd. | Surgical compositions containing sigma-receptor agonists |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4966577A (en) * | 1988-03-16 | 1990-10-30 | Allergan, Inc. | Prevention of lens-related tissue growth in the eye |
| GB0007842D0 (en) * | 2000-03-31 | 2000-05-17 | Spruce Barbara | Sigma receptor ligands and their medical uses |
| US7985405B2 (en) * | 2002-09-17 | 2011-07-26 | Jin Jun Zhang | Treatment solution and method for preventing posterior capsular opacification by selectively inducing detachment and/or death of lens epithelial cells |
| SE0202924D0 (sv) * | 2002-10-03 | 2002-10-03 | Pharmacia Groningen Bv | Compositions for preventing posterior capsular opacification and the use therefor |
| GB0303640D0 (en) * | 2003-02-17 | 2003-03-19 | Univ Aberdeen | An animal model |
-
2004
- 2004-08-27 GB GBGB0419145.8A patent/GB0419145D0/en not_active Ceased
-
2005
- 2005-08-26 WO PCT/GB2005/003373 patent/WO2006021811A2/en not_active Ceased
- 2005-08-26 AT AT05776264T patent/ATE402412T1/de active
- 2005-08-26 EP EP05776264A patent/EP1782065B1/de not_active Expired - Lifetime
- 2005-08-26 US US11/661,482 patent/US20090036464A1/en not_active Abandoned
- 2005-08-26 DE DE602005008445T patent/DE602005008445D1/de not_active Expired - Lifetime
- 2005-08-26 CA CA002578117A patent/CA2578117A1/en not_active Abandoned
- 2005-08-26 ES ES05776264T patent/ES2310365T3/es not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| US20090036464A1 (en) | 2009-02-05 |
| CA2578117A1 (en) | 2006-03-02 |
| GB0419145D0 (en) | 2004-09-29 |
| DE602005008445D1 (de) | 2008-09-04 |
| ES2310365T3 (es) | 2009-01-01 |
| EP1782065A2 (de) | 2007-05-09 |
| WO2006021811A3 (en) | 2006-08-10 |
| EP1782065B1 (de) | 2008-07-23 |
| WO2006021811A2 (en) | 2006-03-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE602005014955D1 (de) | Verbindungen und verfahren zur behandlung von dyslipidämie | |
| EA200900802A1 (ru) | Способы и композиции для лечения амилоидных заболеваний | |
| ATE521357T1 (de) | Verfahren zur behandlung von hepatitis | |
| EA200600078A1 (ru) | Способы и композиции для лечения амилоидных заболеваний | |
| DK1691892T3 (da) | Anbrudsbestandig, coekstruderet doseringsform, der indeholder et aktivt middel og et modvirkende middel, og fremgangsmåde til fremstilling af samme | |
| ATE457989T1 (de) | Bi- und trizyklische substituierte phenyl- methanone als inhibitoren von glycin-i (glyt-1)- transportern zur behandlung der alzheimer- krankheit | |
| EA201070148A1 (ru) | Соединения и способы модулирования фарнезоидного рецептора x (fxr) | |
| EA200700851A1 (ru) | Получение и применение бифенил-4-илкарбониламинокислотных производных для лечения ожирения | |
| ATE537826T1 (de) | Zusammensetzungen aus r(+)- und s(-)-pramipexol sowie verfahren zu ihrer anwendung | |
| EP1595852A4 (de) | Verfahren zur behandlung von ammoniakalischen stickstoffenthaltendem wasser | |
| ATE497763T1 (de) | Verfahren und reagenzien zur behandlung von entzündlichen erkrankungen | |
| DE602004019897D1 (de) | Verfahren zur racematspaltung von 2,4-diamino-3,6-dihydro-1,3,5-triazinen, die sich zur behandlung vkrankungen eignen | |
| ATE439833T1 (de) | Pharmazeutische zubereitung enthaltend ein catechin, ascorbinsäure, prolin und lysin zur behandlung von neoplastischen krankheiten | |
| ATE550015T1 (de) | Verfahren und zusammensetzung zur behandlung von rhinitis | |
| ATE457027T1 (de) | Substituierte 1,4,8-triazaspiroä4.5 decan-2-on- verbindungen zur behandlung von fettsucht | |
| DE602004011494D1 (de) | Synergistische kombination enthaltend roflumilast und einen anticholinergischen wirkstoff ausgewählt aus tiotropiumsalzen für die behandlung von atemwegserkrankungen | |
| DE602004021363D1 (de) | Imidazotriazin verbindungen zur behandlung von krebserkrankungen | |
| DE602006011607D1 (de) | In-vitro-verfahren zur identifizierung von verbindungen zur krebstherapie | |
| ATE402412T1 (de) | Identifikation von verbindungen zur behandlung von nachstar | |
| DE602004022423D1 (de) | Hemmung der s6-kinase-aktivität zur behandlung von insulinresistenz | |
| EA200702136A1 (ru) | Композиции станнсопорфина и их применение | |
| EA200701813A1 (ru) | Новые амидозамещенные 6-фенилфенантридины | |
| ATE503476T1 (de) | Zusammensetzungen und verfahren zur behandlung von krankheiten, die durch infektion mit yersinia spp ausgelöst sind | |
| ATE540920T1 (de) | Aminobenzocycloheptenderivate, verfahren zu deren herstellung und deren verwendung in der therapie | |
| DE602004017425D1 (de) | Pmcol zur behandlung von prostatakrebs |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1782065 Country of ref document: EP |